Ingrid Oakley-Girvan
Academic Appointments
- Consulting Assistant Professor, Health Research & Policy
- Member, Stanford Cancer Institute
Key Documents
Contact Information
- Academic Offices
Personal Information EmailAlternate Contact Cammie D'Entremont Administrative Assistant Email Tel Work 510-608-5049
Professional Overview
Administrative Appointments
- Consulting Assistant Professor, Department of Health Research and Policy, Stanford University School of Medicine (2007 - present)
- Member, Stanford Cancer Institute (2006 - present)
- Research Scientist II, CPIC (2006 - present)
Professional Education
| B.S.: | University of Michigan, Biology (1987) |
| M.P.H.: | Tulane University, Epidemiology (1992) |
| Ph.D.: | Stanford University School of Medicine, Epidemiology (2002) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Genetic epidemiology: Identifying genes that increase susceptibility to cancer or are related to poor survival is a primary interest of Dr. Oakley-Girvan. She is part of the International Consortium for Prostate Cancer Genetics and a member in an international breast and ovarian cancer research group. Through these collaborative teams, which include a broad base of investigators from many institutions and genetic samples from many projects, Dr. Oakley-Girvan is able to focus on investigating genes that may increase a person's susceptibility to prostate, ovarian and breast cancer. In addition, she aims to identify environmental factors that reduce an individual's risk of these cancers, as well as decrease their risk of cancer recurrence and improve their chance of survival.
Survivorship: Dr. Oakley-Girvan is also actively evaluating factors associated with cancer treatment choice, quality of care, treatment outcomes and quality of life. With interests throughout the cancer survivorship continuum and an emphasis on understanding why there are disparities in survivor care, Dr. Oakley-Girvan is also focused on creating solutions. She plans to follow her current studies with education and intervention projects that will effect meaningful change, improve the life of survivors and help eliminate, or, at the very least, reduce cancer health care disparities.
Publications
- Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013; (2): 253-61
- Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet. 2012: 46
- Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate. 2012; (4): 410-26
- Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer. 2012; (1): 65-73
- Double Jeopardy? Age, Race, and HRQOL in Older Adults with Cancer. J Cancer Epidemiol. 2012: 478642
- Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns. 2012; (2): 345-52
Help
Trial Administration